The maker of the weight-loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of these blockbuster ...
Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback